BeStock  
Stocks › Biotechnology › RCUS

Arcus Biosciences RCUS

US equityMarket cap rank #2610Biotechnology
$15.62 −$0.16 (-1.01%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $15.50 -0.77%
Open$15.66
Prev close$15.78
Day range$15.56 – $16.66
Volume1.67M
Market cap$2.25B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$9.00M-65.4% YoY
Operating profit-$131.00M+7.7% YoY
Net profit-$128.00M+5.2% YoY
Diluted EPS-$1.00+21.3% YoY
Free cash flow-$88.00M+9.3% YoY
Operating cash flow-$88.00M

Revenue, last 8 quarters

$26.0MDec '24$28.0MMar '25$160.0MJun '25$26.0MSep '25$33.0MDec '25$17.0MMar '26$41.0MJun '26$9.0MSep '26

Net profit, last 8 quarters

$-94.0MDec '24$-112.0MMar '25$0.0Jun '25$-135.0MSep '25$-106.0MDec '25$-128.0MMar '26$-91.0MJun '26$-128.0MSep '26

Diluted EPS by quarter

-1.03Dec '24-1.14Mar '250.00Jun '25-1.27Sep '25-0.89Dec '25-1.02Mar '26-0.72Jun '26-1.00Sep '26

Free cash flow by quarter

$-101.0MDec '24$-133.0MMar '25$-133.0MJun '25$-97.0MSep '25$-121.0MDec '25$-138.0MMar '26$-119.0MJun '26$-88.0MSep '26

Annual revenue

$78.0MFY20$383.0MFY21$112.0MFY22$117.0MFY23$258.0MFY24$247.0MFY25

Profitability & balance sheet

Operating margin-475.0%
Net margin-453.0%
Return on equity-114.1%
Return on assets-50.6%
Return on invested capital-93.0%
Current ratio3.34
Liabilities / assets56.2%
Cash & investments$630.00M
Total debt$102.00M
Net cash (debt)$528.00M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $9.00M $41.00M $17.00M $247.00M $33.00M
Total Operating Revenue $9.00M $41.00M $17.00M $247.00M $33.00M
Operating Expense $140.00M $137.00M $151.00M $633.00M $147.00M
Selling and Admin Expenses $23.00M $24.00M $29.00M $110.00M $26.00M
-General & Admin Expense $23.00M $24.00M $29.00M $110.00M $26.00M
Research & Development $117.00M $113.00M $122.00M $523.00M $121.00M
Operating Profit -$131.00M -$96.00M -$134.00M -$386.00M -$114.00M
Net Non-Operating Interest Income (Expense) $3.00M $5.00M $6.00M $33.00M $8.00M
Non-Operating Interest Income $6.00M $8.00M $9.00M $41.00M $10.00M
Non-Operating Interest Expense $3.00M $3.00M $3.00M $8.00M $2.00M
Pretax Profit -$128.00M -$91.00M -$128.00M -$353.00M -$106.00M
Tax $0.00 $0.00 $0.00 $0.00 $0.00
Net Profit -$128.00M -$91.00M -$128.00M -$353.00M -$106.00M
Profit from Continuing Operations -$128.00M -$91.00M -$128.00M -$353.00M -$106.00M
Net Income to Parent Company -$128.00M -$91.00M -$128.00M -$353.00M -$106.00M
Net Income to Common Stockholders -$128.00M -$91.00M -$128.00M -$353.00M -$106.00M
Basic EPS -$1.00 -$0.72 -$1.02 -$3.29 -$0.89
Diluted EPS -$1.00 -$0.72 -$1.02 -$3.29 -$0.89
Special Income (Charges) – – – $0.00 $0.00
-Less:Impairment of Capital Assets – – – $0.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $818.00M $924.00M $997.00M $1.14B $1.14B
Total Current Assets $664.00M $756.00M $844.00M $1.01B $1.01B
Cash and Cash Equivalents & Short-Term Investments $630.00M $702.00M $822.00M $981.00M $981.00M
-Cash and Cash Equivalents $151.00M $150.00M $201.00M $222.00M $222.00M
-Short Term Investments $479.00M $552.00M $621.00M $759.00M $759.00M
Receivables $23.00M $41.00M $7.00M $16.00M $16.00M
-Accounts Receivable $18.00M $36.00M $3.00M $11.00M $11.00M
-Accrued Interest Receivable $5.00M $5.00M $4.00M $5.00M $5.00M
Other Current Assets $11.00M $13.00M $15.00M $10.00M $10.00M
Total Non-Current Assets $154.00M $168.00M $153.00M $132.00M $132.00M
Net PPE $33.00M $36.00M $38.00M $40.00M $40.00M
-Gross PPE $33.00M $36.00M $38.00M $90.00M $90.00M
Investments and Advances $64.00M $73.00M $54.00M $29.00M $29.00M
-Available for Sale Securities $64.00M $73.00M $54.00M $29.00M $29.00M
Other Non-Current Assets $57.00M $59.00M $61.00M $63.00M $63.00M
Total Liabilities $460.00M $460.00M $473.00M $508.00M $508.00M
Total Current Liabilities $199.00M $198.00M $209.00M $231.00M $231.00M
Payables $45.00M $35.00M $40.00M $43.00M $43.00M
-Accounts Payable $44.00M $34.00M $39.00M $42.00M $42.00M
-Total Tax Payable $1.00M $1.00M $1.00M $1.00M $1.00M
Current Accrued Expenses $115.00M $119.00M $112.00M $122.00M $122.00M
Short-Term Debt and Capital Lease Obligation $14.00M $13.00M $13.00M $13.00M $13.00M
-Current Capital Lease Obligation $14.00M $13.00M $13.00M $13.00M $13.00M
Current Deferred Liabilities $14.00M $19.00M $34.00M $35.00M $35.00M
Other Current Liabilities $11.00M $12.00M $10.00M $18.00M $18.00M
Total Non-Current Liabilities $261.00M $262.00M $264.00M $277.00M $277.00M
Long Term Debt and Capital Lease Obligation $102.00M $101.00M $100.00M $99.00M $99.00M
-Long Term Debt $102.00M $101.00M $100.00M $99.00M $99.00M
Non-Current Deferred Liabilities $34.00M $37.00M $45.00M $43.00M $43.00M
Other Non-Current Liabilities $125.00M $124.00M $119.00M $135.00M $135.00M
Total Equity $358.00M $464.00M $524.00M $631.00M $631.00M
Stockholders' Equity $358.00M $464.00M $524.00M $631.00M $631.00M
Capital Stock $2.19B $2.17B $2.14B $2.12B $2.12B
-Common Stock $2.19B $2.17B $2.14B $2.12B $2.12B
Retained Earnings -$1.83B -$1.70B -$1.61B -$1.49B -$1.49B
Gains/Losses Not Affecting Retained Earnings -$2.00M -$1.00M -$1.00M – –
-Accumulated Depreciation – – – -$50.00M -$50.00M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$88.00M -$119.00M -$138.00M -$482.00M -$120.00M
Net cash flow from continuing operations -$88.00M -$119.00M -$138.00M -$482.00M -$120.00M
Net Income from Continuing Operations -$128.00M -$91.00M -$128.00M -$353.00M -$106.00M
Depreciation & Depletion & Amortization $2.00M $3.00M $2.00M $10.00M $3.00M
Other Non-Cash Items $3.00M $4.00M $2.00M $8.00M $1.00M
Change in Working Capital $21.00M -$47.00M -$31.00M -$194.00M -$30.00M
-Change in Receivables $18.00M -$3.00M $8.00M $9.00M $0.00
-Change in Payables and Accrued Expense $10.00M -$5.00M -$3.00M $24.00M $0.00
-Change in Other Current Assets $4.00M $0.00 -$3.00M $5.00M $0.00
-Change in Other Current Liabilities -$2.00M -$2.00M -$16.00M $8.00M -$4.00M
-Change In Other Working Capital -$9.00M -$37.00M -$17.00M -$240.00M -$26.00M
Net cash flow from investing $82.00M $52.00M $114.00M $66.00M -$182.00M
Net Cash Flow from Continuing Investing Activities $82.00M $52.00M $114.00M $66.00M -$182.00M
Net PPE Purchase and Sale $0.00 $0.00 $0.00 -$2.00M -$1.00M
Net Investment Purchase and Sale $82.00M $52.00M $114.00M $68.00M -$181.00M
Financing Cash Flow $7.00M $16.00M $3.00M $488.00M $286.00M
Net Cash Flow from Continuing Financing Activities $7.00M $16.00M $3.00M $488.00M $286.00M
Net Issuance Payments Of Debt $0.00 – – $49.00M $0.00
Net Common Stock Issuance $0.00 $0.00 $0.00 $429.00M $279.00M
Proceeds from Stock Option Exercised $7.00M $16.00M $3.00M $10.00M $7.00M
Ending Cash Balance $154.00M $153.00M $204.00M $225.00M $225.00M
Net Change in Cash $1.00M -$51.00M -$21.00M $72.00M -$16.00M
Beginning Cash Balance $153.00M $204.00M $225.00M $153.00M $241.00M
Free Cash Flow -$88.00M -$119.00M -$138.00M -$484.00M -$121.00M

Discussion

No comments yet — be the first to weigh in on RCUS.

Sign in to join the discussion.

Scroll to Top